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Introduction
Since the introduction of dynamic
contour tonometry (DCT), the ocular
pulse amplitude (OPA) has become of
increasing interest for clinical applica-
tion (Kaufmann et al. 2004; Kniestedt
et al. 2004; Kanngiesser et al. 2005).
Intraocular pressure (IOP) has been
shown to fluctuate with the heart
beat. During the systolic phase, IOP
increases by 2–3 mmHg compared to
the diastolic phase (Kaufmann et al.
2006). This difference is the OPA and
is mainly generated by pulsatile filling
of the choroid with blood via the
short ciliary arteries (Thiel 1928;
Bynke & Schele 1967; Perkins 1981;
Schmidt et al. 2001). During the filling
phase, the outer layers of the globe
inhibit the choroid from expanding
outwards. The choroid thickens
because of the influx of blood, which
inevitably leads to an increase in IOP.
The OPA has been investigated and
evaluated in different clinical settings:
to detect carotid artery stenosis, to
differentiate between arteritic and
nonarteritic anterior ischaemic optic
neuropathy, to observe the course of
Grave’s disease and in particular to
acquire a new prognostic parameter in
different types of glaucoma (Perkins
1985; Bienfang 1989; Tsai et al. 2005;
Kniestedt et al. 2006; Romppainen
et al. 2007). However, to be able to
use the OPA for diagnostic purposes,
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ABSTRACT.
Purpose: To investigate changes in ocular pulse amplitude (OPA) during a
short-term increase in intraocular pressure (IOP) and to assess possible influ-
ences of biometrical properties of the eye, including central corneal thickness
(CCT) and axial length.
Methods: In a prospective, single centre study, OPA and IOP as measured by
dynamic contour tonometry (DCT) were taken before baseline- and post-OPA
(delta) intravitreal injection of 0.05 ml anti-vascular endothelial growth factor
agents. Analysis was performed employing linear regression with baseline- and
post (delta)-OPA differences as the dependent and post-IOP as well as delta
IOP as the independent variable. A multilinear regression analysis with delta
OPA as the dependent variable and baseline IOP, post-IOP, CCT and axial
length as independent variables was conducted.
Results: Forty eyes of 40 patients were included. IOP and OPA increased sig-
nificantly after injection (IOP mean increase ± SD: 17.83 ± 9.83 mmHg,
p < 0.001; OPA mean increase ± SD: 1.39 ± 1.16 mmHg, p < 0.001). For
every mmHg increase in IOP, the OPA showed a linear increase of
0.05 mmHg (slope 0.05, 95% CI: 0.02–0.09, p = 0.003, r2 = 0.20). Multiple
regression analysis with delta OPA as the dependent variable revealed a par-
tial correlation coefficient of 0.47 (p = 0.003) for post-IOP as the only signif-
icant contribution.
Conclusion: A clear positive relationship between OPA measurements and
IOP levels was shown in a clinical routine setting using DCT focusing
on baseline and postinterventional comparisons of OPA values after intravitre-
al injections in patients with exudative age related macular degeneration.
When considering the OPA for diagnostic purposes, we recommend indication
of corresponding IOP values.
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confounding influences on the OPA
need to be determined. As of yet,
OPA has been shown to be dependent
on heart rate and axial length (James
et al. 1991; Trew et al. 1991).
Recent studies have reported a posi-
tive linear correlation between IOP and
OPA readings, i.e. eyes with higher IOP
measurements showed higher OPA val-
ues (Kaufmann et al. 2006; Kniestedt
et al. 2006). This result seems surprising
at first, because choroidal blood flow
has been shown to decrease when IOP is
elevated, which should lead to a
decrease in OPA (Dollery et al. 1968;
Langham et al. 1989; Polska et al.
2007). In contrast, Davenger et al. had
found an enlarged ophthalmic pulse at
higher IOP already in 1964. Lawrence
et al. (1966) showed in an animal
experiment with rabbits and dogs and
Dastiridou et al. (2009) in a human
experiment that OPA increases after an
increase in IOP. Their experiments
were performed by infusing micro-
volumes of saline to increase IOP from
15 to 40 mmHg and IOP was measured
by manometry. Furthermore Dastiri-
dou et al. showed a median OPA
increase of 0.075 mmHg ⁄mmHg (range
0.006 ⁄ 0.140).
To our knowledge, no study has been
conducted showing changes in OPA
before and after a short-term increase in
IOP in human eyes as of yet. The pur-
pose of this study was to investigate
these changes and to assess possible
influences by biometrical properties of
the eye, including central corneal thick-
ness (CCT) and axial length.
Methods
This was a prospective, single centre
study conducted at the Department of
Ophthalmology, University Hospital of
Zurich. As an easily accessible and non-
hazardous in vivo human eye model for
short-term IOP changes, we chose eyes
of patients with exudative age related
macular degeneration (AMD) who
underwent intravitreal anti-vascular
endothelial growth factor (VEGF)
treatment. It is known that IOP is
increased shortly after the intervention
(Kim et al. 2008; Knecht et al. 2009).
Patients with exudative AMD were
enrolled. Informed written consent was
obtained from each subject, adhering
to the tenets of the Declaration of Hel-
sinki. The study protocol was approved
by the local ethics committee. Patients
with a history of glaucoma, a history of
ocular surgery (except previous intravi-
treal injections and uncomplicated
cataract surgery), use of IOP-lowering
agents, inability to comply with
repeated contact IOP measurements or
an IOP >25 mmHg prior to injection
were excluded from the study.
All injections were performed by
the same ophthalmic surgeon (SM)
employing two different injection tech-
niques (tunnelled or straight scleral in-
travitreal injection) (Knecht et al.
2009). This protocol leads to different
amounts of vitreous reflux and there-
fore to different postoperative IOP
levels after identical amounts (in this
study: 0.05 ml) of anti-VEGF injec-
tion (Benz et al. 2006; Knecht et al.
2009). The patients were randomly
allocated to one injection technique.
The main outcome measures were
postoperative (post)-OPA and postop-
erative-IOPvalues. Secondly,we investi-
gated the potential relationship between
the IOP before and after intravitreal
injection and the difference between
baseline and post-OPA (delta OPA).
Additionally, the influence of CCT and
axial length onOPAchanges after short-
termIOPelevationwasassessed.
IOP, OPA, central corneal thickness and
axial length measurement procedure
Intraocular pressure and OPA mea-
surements were performed with a slit
lamp-mounted dynamic contour tono-
meter (PASCAL; Swiss Microtechnol-
ogy AG, Port, Switzerland) by the
same experienced investigator (PBK).
Post-IOP measurements were taken
immediately after moving the patient
from the operating table to the slit
lamp. Only readings with the quality
index (‘Q’) 1 or 2 (range: 1–5, 5 being
the lowest measurement quality) were
considered for analysis. Because the
displayed result on the pressure device
cannot be modified by the investigator,
the IOP readings were not masked.
Central corneal thickness and axial
length were determined with the To-
mey AL-2000 biometer ⁄pachymeter
(Tomey Corp., Nagoya, Japan). The
average of 10 measurements was
included in statistical analysis.
Statistical analysis
Normal distribution of the data was
analysed using the Kolmogorov–Smir-
nov test. Baseline OPA and post-OPA
as well as baseline IOP and post-IOP
were compared employing a paired
t-test. Delta OPA was calculated for
every patient and two linear regres-
sions were performed with post-IOP
and delta IOP as the independent and
delta OPA as the dependent variable.
A multiple regression analysis was
used to analyse relations between
delta OPA and independent variables
(baseline IOP, post-IOP, CCT, axial
length). Differences in delta OPA and
delta IOP between patients treated
with the tunnelled versus the straight
intravitreal injection technique were
assessed employing an unpaired t-test.
A p-value below 0.05 was consid-
ered to be statistically significant. No
outliers were excluded. Randomiza-
tion was performed using http://www.
randomization.com. Statistical analy-
sis was performed using the statistics
software GraphPad Prism Version 4.02
(GraphPad software Inc., San Diego,
CA, USA).
Results
Six patients were excluded because of
IOP readings >25 mmHg prior to
injection. One patient was excluded
due to failure of output routine of
the DCT device to calculate an accu-
rate IOP because of a low OPA
(<1.0 mmHg) prior to the injection.
Forty eyes of 40 patients remained eli-
gible for the study. Baseline character-
istics and demographics of the study
patients are presented in Table 1. No
intraoperative or short-term postoper-
ative complications occurred.
Ocular pulse amplitude changes
There was a significant increase in IOP
(mean ± SD in mmHg) right after the
injection (Fig. 1A, post-IOP 36.58 ±
9.7, range: 14.20–58.10, p < 0.001,
mean of paired differences: 17.83 ±
9.83, 95% confidence interval (CI)
14.68–20.97). A significant increase in
OPA right after the injection was also
observed (Fig. 1B, post-OPA 4.13 ±
1.65 range: 1.40 –7.70, p < 0.001,
mean of paired differences: 1.39 ±
1.16, 95% CI 1.02–1.76). Twenty-one
patients were injected with the tun-
nelled intravitreal injection technique
and 19 with straight intravitreal injec-
tion. There was no significant differ-
ence between the two injection
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techniques regarding delta OPA (mean
of differences tunnelled versus straight
intravitral injection: 0.58 ± 0.36
mmHg, p = 0.118) or delta IOP (mean
of differences tunnelled versus straight
intravitral injection: 3.19 ± 3.11
mmHg, p = 0.311). A summary of all
measurements splitted for different in-
travitreal injection techniques is pre-
sented in Table 2.
Regression analyses
Post-IOP showed a statistically signifi-
cant linear regression with the corre-
sponding delta OPA values (slope
0.05, 95% CI: 0.02–0.09, p = 0.003,
r2 = 0.20, Fig. 2A). For every mmHg
increase in IOP, the OPA showed
an increase of 0.05 mmHg. A similar
analysis with delta IOP as the
independent variable was also statis-
tically significant (slope 0.06, 95%
CI: 0.03–0.09, p = 0.001, r2 = 0.26,
Fig. 2B).
Multiple regression analysis with
delta OPA as the dependent variable
and baseline IOP, post-IOP, CCT and
axial length as independent variables
revealed a partial correlation coeffi-
cient of )0.26 (p = 0.084) for baseline
IOP, 0.47 (p = 0.003) for post-IOP,
0.09 (p = 0.518) for CCT and 0.024
(p = 0.873) for axial length. The cor-
relation coefficient r was 0.525,
p < 0.021. Multicollinearity was not
observed.
Discussion
This study reveals three main findings.
First, there is a significant increase in
OPA upon short-term IOP increase.
Secondly, we found no influence on
OPA increase by CCT or axial length.
Additionally, the extent of the OPA
increase became less at very high
IOPs.
Several studies established that
increased IOP results in reduction of
the choroidal blood flow (Dollery et al.
1968; Polska et al. 2007). Because
Schilder (1994) suggests that the OPA
may be regarded as a clinical window
to ocular blood flow, in particular its
pulsatile component (Silver et al.
1989), a decrease in choroidal blood
flow should lead to a decrease in OPA,
as shown by Langham et al. (1989).
Our data clearly show the opposite
and are consistent with results from
Dastiridou et al. (2009) and Stalmans
et al. (2008), who also reported an
increase in OPA when IOP is elevated.
It seems that high OPA measurements
at elevated IOP levels are not necessar-
ily a direct sign of increased choroidal
blood flow and may be misleading
when applied for this particular diag-
nostic purpose. It is known that the
elastic properties of the eye change at
higher IOP levels (Silver & Geyer
(A)
(B)
Fig. 1. Box plots show the distribution of
intraocular pressure (IOP) (A) and ocular
pulse amplitude (OPA) (B) measurements
before (baseline), and <1 min after (post)-in-
travitreal injection of 0.05 ml anti-VEGF
agent.
Table 1. Baseline demographic information.
Age (years ± SD)
Mean 79 ± 8
Range 63–91
Sex (%)
Male 13 (32.5)
Female 27 (67.5)
Study eye (%)
Right 22 (55)
Left 18 (45)
Drug (0.05 ml) (%)
Ranibizumab 36 (90)
Bevacizumab 4 (10)
Lens status in study eye (%)
Phakia 23 (57.5)
Pseudophakia 17 (42.5)
Measurements (mmHg ± SD)
Intraocular pressure 18.75 ± 3.20
Ocular pulse amplitude 2.74 ± 1.03
Biometrical properties
Central corneal thickness
(lm ± SD)
549.93 ± 32.03
Axial length (mm ± SD) 23.18 ± 0.93
Table 2. A summary of the mean OPA and IOP measurements (mmHg ± SD) splitted for different injection techniques.
Baseline OPA Post OPA Delta OPA Baseline IOP Post IOP Delta IOP
Tunnelled injected patients (n = 21) 2.84 ± 1.00 4.51 ± 1.57 1.67 ± 1.26 18.19 ± 3.19 37.54 ± 8.45 19.35 ± 9.26
Straight injected patients (n = 19) 2.62 ± 1.08 3.71 ± 1.67 1.09 ± 0.99 19.37 ± 3.18 35.53 ± 11.05 16.15 ± 10.42
OPA, ocular pulse amplitude; IOP, intraocular pressure.
(A)
(B)
Fig. 2. (A) Concordance of intraocular pres-
sure (IOP) measurements after intravitreal
injection (Post-IOP) and difference of ocular
pulse amplitude measurements before and
after intravitreal injection (Delta OPA). Black
solid line: the linear function of the data
Post-IOP versus Delta OPA. Linear regres-
sion using Delta OPA as the dependent vari-
able and Post-IOP as the independent
variable gives a slope of 0.05. In patients
numbered 1 through 4, the OPA increase is
markedly reduced compared to patients with
post-IOP levels <49 mmHg. (B) A similar
analysis using delta OPA as well as the
dependent but delta IOP as the independent
variable (slope 0.06). Patient no. 5 shows a
high delta IOP similar to no. 1–4 but a mark-
edly higher delta OPA which might be
explained by a lower post-IOP (47 mmHg).
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2000). Scleral wall tension increases
and exerts more resistance to the
expanding choroid during the systolic
phase. The pulsatile increase in choroi-
dal thickness is pronounced and leads
to an increase in OPA rather than an
additional expansion of the already
prestretched outer shells of the globe
(Wegner 1930).
The continuous linear increase in
the difference between baseline and
post-OPA and post-IOP seems to dis-
continue at very high values above
49 mmHg. Regarding the post-IOP
levels of patients numbered 1 through
4 (two with each injection technique)
in Fig. 2, the OPA increase is tenden-
tially lower compared to most
patients with post-IOP levels below
49 mmHg. Patient no. 5 shows a high
delta IOP similar to no. 1–4 but a
markedly higher delta OPA. Because
the post-IOP is 47 mmHg, this
patient’s measurements do not con-
trast the postulated hypothesis. How-
ever, this may be attributed to
random scatter of data. An infinite
continuity of an OPA increase is
obsolete, because the ocular perfusion
is defined by the pressure gradient
between the blood pressure within the
ophthalmic artery and the IOP (Lang-
ham et al. 1989; Polska et al. 2007).
IOP levels greater than the blood
pressure within the ophthalmic artery
lead to an interruption of blood flow
into the eye and therefore annihila-
tion of the OPA. Bynke reported in
early 1968 that in an experimental set-
ting with rabbit eyes, the increase in
IOP is paralleled by an increase in
OPA (Bynke 1968). At higher IOP
levels, the OPA diminished again.
This might also be true for live
human eyes. However, because our
protocol did not include arterial
blood pressure measurements, and
because there was only a small num-
ber of patients with very high IOP
values, further studies are needed to
confirm this hypothesis.
It is well known that biomechanical
properties of the eye might influence
the OPA. A long axial length leads to
smaller OPA measurements because
of several reasons:
(1) The longer the eye, the higher the
intraocular volume and the smaller
the relative intraocular volume change
caused by the same amount of choroi-
dal blood inflow.
(2) Changes in ocular rigidity with
increasing axial length.
(3) The longer the axial length, the
less the amount of pulsatile flow
(To’mey et al. 1981; James et al.
1991).
Thus, we assumed that a longer axial
length would lead to a smaller
increase in OPA after increasing the
IOP. However, our multilinear regres-
sion analysis did not reveal such a
dependency. There may be two under-
lying reasons: First, we also did not
find any correlation between baseline
OPA and axial length (Pearson’s
r = 0.07, p = 0.66), in contrast to
other studies (James et al. 1991; Kauf-
mann et al. 2006; Berisha et al. 2010).
Kaufmann et al. reported a negative
correlation of OPA and axial length.
Their study population showed a
median axial length of 24.3 mm with
an interquartile range (IQR) from
22.8 to 26.4 mm. Also, the study of
Berisha et al. reported a mean axial
length of 25.15 mm with a standard
error of mean of 2.07 mm and a wide
range from 19.98 to 29.50 mm. Our
study population showed a median of
23.17 mm with a considerably smaller
IQR from 22.58 to 23.61 mm. This
might be the reason why we did not
found such correlation. One strength
of the study was to be able to exclude
axial length as an influence on possi-
ble correlation of IOP with OPA.
Secondly, because only 0.05 ml of
anti-VEGF agent was injected, longer
eyes might have shown less increase in
IOP and therefore the OPA increase
was not that pronounced. However,
this would have been indicated by our
multilinear regression analysis, where
we did not find multicollinearity. CCT
may also influence IOP and therefore
OPA measurements, which is exten-
sively discussed in the literature. DCT
has been shown to be largely indepen-
dent of CCT, which is also confirmed
by our own data (Kniestedt et al.
2004; Kaufmann et al. 2006).
A deficit in our study design might
be the fact that our model is based on
eyes with pathologic changes, i.e. exu-
dative AMD. Pallikaris et al. (2006)
reported that eyes with exudative
AMD show increased ocular rigidity
measurements. This leads to a steeper
pressure–volume relation and, accord-
ing to the study reported by Friedman
et al. (1989), to an impaired filling of
the vortex veins as well as a an
increase in resistance of the choroidal
vessels. Accordingly, Mori et al.
(2001) reported a low OPA in patients
with exudative AMD compared with
patients with non-exudative AMD
and normal subjects. Overall decre-
ased choroidal blood with increasing
severity of the AMD [e.g.(Grunwald
et al. 2005)] would impair a demon-
stration of a positive relationship
between IOP and OPA and therefore
rather strengthens our findings. In
addition, no significant impairment of
the choroidal autoregulation has been
shown for patients with AMD (Met-
elitsina et al. 2010). Only within a – in
comparison with the whole choroidal
circulation – relatively small choroidal
neovascularization (CNV), a second-
ary focal increase in blood flow as
indicator for focal loss of autoregula-
tion has been reported in patients with
AMD (Pournaras et al. 2006). It is
highly unlikely that this might influ-
ence the OPA.
The arterial blood pressure, as dem-
onstrated by Polak et al. (2003), has a
small but significant influence on cho-
roidal blood flow. And because a
decrease in choroidal blood flow
should lead to a decrease in OPA, as
shown by Langham et al. (1989), it is
hence reasonable to assume that the
OPA must be dependent on arterial
blood pressure. However, there are
studies that clearly show the opposite
(Grieshaber et al. 2009; Schmidt et al.
1998), where no changes in OPA
despite different or varying (in terms of
physical exercise) arterial blood pres-
sure were found. We therefore chose
not to measure the arterial blood pres-
sure because of lack of methodological
evidence. The lack of arterial blood
pressure measurements however did
not give us the possibility to declare
whether the delta IOP was influenced
by systemic hypertension. Kiel (1995))
and in particular Bayerle-Eder et al.
(2005) demonstrated a dependence of
the ocular rigidity on mean arterial
blood pressure. It is reasonable to
assume that elevated mean arterial
blood pressure, which yields an
increased ocular rigidity, might lead to
an increased elevation in OPA because
of the stronger resistance of the ocular
shells as described in the introduction.
To describe the influence of IOP on
the function of the eye, considerable
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effort has been made to establish a
model. Silver & Geyer (2000) devel-
oped a more general relationship
between pressure and volume on the
basis of a globe. Kotliar et al. (2007)
published a biomechanical model also
using a globe shape. Berisha et al.
(2010) elaborated on a geometrical
model with different radii between the
sclera and the choroid ⁄ retina to
describe the dependence on ocular
pulse pressure. These articles portray
a highly sophisticated understanding
of the physiological changes of the
globe shape during different phases of
the cardiac cycle.
These models may be amended by
further considerations. We can assume
two interface areas, one where the eye
encounters a surrounding allowing
only a very low compressibility, thus
the posterior segment, and in contrast,
the highly compressive air interface of
the anterior segment. The lens plane
could be considered as the dividing
anatomical site, because the eyelid
exerts only little rigidity on this part
of the sclera. Adhering to these
assumptions, most of the action on a
change in internal pressure of the eye,
being it static or dynamic, will mani-
fest at the cornea. The combined lens
and iris diaphragm might act dynami-
cally as a moving plunger. To under-
stand the physical properties, we
would then consider the cornea as a
flexible membrane in a first approxi-
mation. Assuming viscoelastic proper-
ties, one expects a linear dependence
on e.g. increasing IOP. The dynamic
behaviour OPA, our site of interest,
should also behave linear. The topic
of this work was not designed to
prove a pursuing model, but it might
be worthwhile to design further stud-
ies to do so.
In conclusion, we showed a clear
positive correlation between OPA and
IOP measurements in a clinical rou-
tine setting using DCT focusing on
baseline and postinterventional com-
parisons of OPA values in patients
with exudative AMD, and that this
linear correlation might be interrupted
at very high IOP levels, assuming an
impaired filling of the blood vessels
within the eye. We found no correla-
tion of the increase in OPA with bio-
metrical properties of the eye. In
further studies employing the OPA for
diagnostic purposes, we urgently rec-
ommend indication of the correspond-
ing IOP values.
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